Search results
Today’s CD Rates for May 1, 2024: Up to 5.92% APY
Market Watch· 5 days agoAn overview of the national average CD rates for select standard term lengths and data on each term’s basis point increase or decrease history is...
Here’s how much investing $10,000 in a CD right now could earn you in 1 year
Bankrate via Yahoo Finance· 4 days agoNational average 1-year CD...
What Is a CD (Certificate of Deposit)?
GoBankingRates via AOL· 1 day agoA certificate of deposit typically offers a higher rate of return than a traditional savings account. Find out which type of CD might be right for you.
Citibank CD Rates 2024: How They Compare - NerdWallet
Nerdwallet· 3 days agoCitibank has standard fixed-rate CDs as well as no-penalty and step-up CDs, which are less common...
I’m a Financial Planner: What Not To Do When Your CD Matures
GOBankingRates via Yahoo Finance· 6 days agoFor people who don't like risky investments, certificates of deposit (CDs) are often a great way to...
Cameco Co. (NYSE:CCJ) Position Cut by Russell Investments Group Ltd.
ETF DAILY NEWS· 6 hours agoRussell Investments Group Ltd. trimmed its stake in Cameco Co. (NYSE:CCJ – Free Report) (TSE:CCO) by 24.0% during the fourth quarter, according to its most recent disclosure with the SEC. The ...
Zurcher Kantonalbank Zurich Cantonalbank Sells 1,074 Shares of Columbus McKinnon Co. (NASDAQ:CMCO)
ETF DAILY NEWS· 8 hours agoZurcher Kantonalbank Zurich Cantonalbank decreased its stake in shares of Columbus McKinnon Co....
MGIC Investment Co. (MTG) To Go Ex-Dividend on May 8th
ETF DAILY NEWS· 4 hours agoMGIC Investment Co. (NYSE:MTG – Get Free Report) announced a quarterly dividend on Thursday, April...
Ovid Therapeutics (NASDAQ:OVID) Now Covered by B. Riley
ETF DAILY NEWS· 4 days agoAnalysts at B. Riley assumed coverage on shares of Ovid Therapeutics (NASDAQ:OVID – Get Free Report) in a research report issued on Tuesday, MarketBeat reports. B. Riley’s target price suggests ...
F5 (NASDAQ:FFIV) PT Lowered to $189.00
ETF DAILY NEWS· 4 days agoF5 (NASDAQ:FFIV – Get Free Report) had its price target decreased by investment analysts at Barclays from $206.00 to $189.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage ...
